DG
David Gyorki
Credentials: ·
History
- 2007–2011
Medical School
Research
Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma
New England Journal of Medicine · 2024 · 438 citations
Annals of Surgical Oncology · 2021 · 221 citations
Systemic Therapy for Melanoma: ASCO Guideline
Systematic review or meta-analysis · Journal of Clinical Oncology · 2020 · 214 citations
13 papers
11 papers
11 papers
10 papers
9 papers
8 papers
8 papers · 4 as a fellow
7 papers
